Changes to pharmacy regulations effective January 31, 2020

January 30th, 2020

Changes to pharmacy regulations effective January 31, 2020

As communicated by the Department of Health & Community Services, amendments have been made to the Authorization to Prescribe Regulations under the Pharmacy Act, 2012 that permit NL pharmacists to prescribe for Hepatitis A, Hepatitis B (including the TWINRIX vaccine), shingles (Herpes Zoster), Human Papillomavirus (HPV) and chickenpox (Varicella Zoster). Newfoundlanders and Labradorians will be able to visit their local pharmacy for these vaccines without requiring a prescription from a physician. The public should call their pharmacy ahead of time to ensure these services are up & running as it may take time to implement.

See Department of Health & Community Services Release here.

Information for registrants: In accordance with these amendments, revisions to the Standards of Practice – Prescribing by Pharmacists were approved by the Board at their November 2019 meeting. Please read the updated standards before expanding your scope of practice to include the regulation changes.

Key revisions include:

  • A new section related to prescribing Schedule I, II or III products for a limited number of preventable diseases
  • Changes to the General Standards section, particularly sub-sections related to assessment, documentation and notification/communication, to reflect the availability of the electronic health record
  • Changes made to ensure that the standards can be utilized by both community and hospital pharmacists
  • Streamlined section related to Adapting a Prescription, to reduce perceived limitations on this category of prescribing

The revised standards will be discussed during the February 11, 2020 Professional Practice Webinar. An official email with webinar details will follow within the next week. For past Professional Practice Webinar recordings, visit the Webinars page on https://learn.nlpb.ca/.

Any specific questions about the revised standards can be directed to inforx@nlpb.ca.

 

©2020 Newfoundland & Labrador Pharmacy Board